Literature DB >> 21133723

Assessment of adenosine triphosphate-binding cassette subfamily B member 1 (ABCB1) mRNA expression in patients with de novo chronic myelogenous leukemia: the role of different cell types.

Zdenek Racil, Filip Razga, Katerina Machova Polakova, Lucie Buresova, Vaclava Polivkova, Dana Dvorakova, Daniela Zackova, Hana Klamova, Petr Cetkovsky, Jiri Mayer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21133723     DOI： 10.3109/10428194.2010.533220

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  8 in total

Review 1.  Overexpression of ABCB1 as prediction marker for CML: How close we are to translation into clinics?

Authors:  V Némethová; F Rázga
Journal:  Leukemia       Date:  2016-10-21       Impact factor: 11.528

2.  Gene expression patterns as predictive biomarkers in hematology-oncology: principal hurdles on the road to the clinic.

Authors:  Filip Rázga; Veronika Némethová
Journal:  Haematologica       Date:  2017-01       Impact factor: 9.941

Review 3.  Purinergic signalling and cancer.

Authors:  Geoffrey Burnstock; Francesco Di Virgilio
Journal:  Purinergic Signal       Date:  2013-12       Impact factor: 3.765

4.  The predictive value of human organic cation transporter 1 and ABCB1 expression levels in different cell populations of patients with de novo chronic myelogenous leukemia.

Authors:  Filip Razga; Zdenek Racil; Katerina Machova Polakova; Lucie Buresova; Hana Klamova; Daniela Zackova; Dana Dvorakova; Vaclava Polivkova; Petr Cetkovsky; Jiri Mayer
Journal:  Int J Hematol       Date:  2011-09-08       Impact factor: 2.490

5.  ABCB1 regulation through LRPPRC is influenced by the methylation status of the GC -100 box in its promoter.

Authors:  Stephany Corrêa; Renata Binato; Bárbara Du Rocher; Gerson Ferreira; Paola Cappelletti; Sheila Soares-Lima; Luis Felipe Pinto; André Mencalha; Eliana Abdelhay
Journal:  Epigenetics       Date:  2014-07-02       Impact factor: 4.528

6.  Wnt/β-catenin pathway regulates ABCB1 transcription in chronic myeloid leukemia.

Authors:  Stephany Corrêa; Renata Binato; Bárbara Du Rocher; Morgana T L Castelo-Branco; Luciana Pizzatti; Eliana Abdelhay
Journal:  BMC Cancer       Date:  2012-07-23       Impact factor: 4.430

7.  ABCB1 haplotypes do not influence transport or efficacy of tyrosine kinase inhibitors in vitro.

Authors:  Karin Skoglund; Samuel Boiso Moreno; Maria Baytar; Jan-Ingvar Jönsson; Henrik Gréen
Journal:  Pharmgenomics Pers Med       Date:  2013-08-20

8.  ABCB1 and BMI1 mRNA expression in patients with chronic myeloid leukemia: impact on imatinib efficacy.

Authors:  Ahmed M L Bedewy; Shereen M Elmaghraby; Noha S Kandil
Journal:  Blood Res       Date:  2019-03-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.